Disease Info Card

Nasopharyngeal Diseases

Information about Nasopharyngeal Diseases: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Nasopharyngeal Diseases

Most recent studies have shown that Nasopharyngeal Diseases shares some biological mechanisms with airway-obstruction, cancer-of-nasopharynx, carcinoma, ear-inflammation, head-and-neck-neoplasms, infective-disorder, influenza, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, nasopharyngeal-neoplasms, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, otitis-media, pneumococcal-infections, pneumonia, respiratory-tract-infections, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Nasopharyngeal Diseases, and have been seen in publications frequently: Biofilm Formation, Cell Growth, Cell Proliferation, Coagulation, Drug Resistance, Excretion, Immune Response, Inflammatory Response, Innervation, Localization, Methylation, Pathogenesis, Phagocytosis, Reflex, Reverse Transcription, Secretion, Transport, Tropism, Viral Replication, Virulence

Quite a number of genes have been found to play important roles in Nasopharyngeal Diseases, such as ACAT1, CAT, COL2A1, CRAT, CSF2, GLYAT, IL10, IL13, IL6, LAMC2, MID1, NPC1, NPS, PDLIM7, POMT1, SLC25A5, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.